Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Depreciation & Amortization - Total (2009 - 2019)

Novartis Ag's (NVS) quarterly Depreciation & Amortization - Total came in at $9.6 billion in Q4 2019, up 683.05% quarter-over-quarter from -$1.7 billion in Q4 2014.

Analysis

Novartis Ag (NVS) Depreciation & Amortization - Total (2009 - 2019) Analysis & Trends

Novartis Ag has disclosed Depreciation & Amortization - Total across 7 years of filings, most recently posting $9.6 billion for Q4 2019.

  • In Q4 2019, Depreciation & Amortization - Total changed N/A year-over-year to $9.6 billion; the TTM figure through Dec 2019 stood at $4.5 billion (changed N/A YoY), while the FY2023 annual figure was -$144.0 million, up 88.08% from the prior year.
  • Depreciation & Amortization - Total came in at $9.6 billion for Q4 2019 at Novartis Ag, up from -$1.7 billion in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $9.6 billion in Q4 2019 to a low of $9.6 billion in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 9.63 Bn
Dec 31, 2014 -1.65 Bn
Dec 31, 2013 -1.76 Bn
Dec 31, 2012 -1.70 Bn
Dec 31, 2011 -1.73 Bn
Mar 31, 2011 426.00 Mn
Dec 31, 2010 -1.36 Bn
Mar 31, 2010 275.00 Mn
Dec 31, 2009 -1.24 Bn
Jun 30, 2009 498.00 Mn
Mar 31, 2009 338.00 Mn